The Chemours Company
NYSECC arrived at its Q1 2026 earnings release riding a 30% one-month rally — and then promptly fell back as the results hit the tape. The week captured a classic pre-earnings long squeeze in reverse. The stock closed at $27.94 on May 5, up 8.7% on the week and nearly 30% higher than where it traded a month ago. Options traders had been leaning hard into the rally: the put/call ratio…
Snapshot as of 22 Jun 2026
CC arrived at its Q1 2026 earnings release riding a 30% one-month rally — and then promptly fell back as the results hit the tape. The week captured a classic pre-earnings long squeeze in reverse. The stock closed at…
The Chemours Company walks into its Q1 2026 earnings report with one of the sharpest momentum stories in the chemicals sector — up 30% in a month — and options traders who appear to be chasing the move rather than…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CC — free to start on ORTEX.
Sign up for free →Open CC on ORTEX